Ardelyx (ARDX) Gains from Investment Securities (2013 - 2025)
Ardelyx posted quarterly Gains from Investment Securities of -$6000.0 for Q4 2025, up 99.19% year-on-year from -$3012.1 in Q4 2024, and up 99.82% on a QoQ basis from -$3.4 million in Q3 2025.
Ardelyx (ARDX) has 13 years of Gains from Investment Securities data on file, last reported at -$6000.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Investment Securities rose 99.19% year-over-year to -$6000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.7 million (down 169.71% YoY), and the FY2025 full-year result was $485000.0, up 82.33% from the prior year.
- Gains from Investment Securities for Q4 2025 stood at -$6000.0, up from -$3.4 million in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $2.2 million in Q1 2025 and bottomed at -$3.4 million in Q3 2025.
- The 5-year median for Gains from Investment Securities is $19000.0 (2023), against an average of $99066.7.
- The widest annual swing landed in 2021, when Gains from Investment Securities soared 67300.0%; it then tumbled 2425.0% in 2024.
- A 5-year view of Gains from Investment Securities shows it stood at $674000.0 in 2021, then plunged by 99.26% to $5000.0 in 2022, then jumped by 540.0% to $32000.0 in 2023, then sank by 2425.0% to -$744000.0 in 2024, then surged by 99.19% to -$6000.0 in 2025.
- The last three Gains from Investment Securities figures came in at -$6000.0 (Q4 2025), -$3.4 million (Q3 2025), and $1.7 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6,000.00 |
| Dec 31, 2025 | -6,000.00 |
| Sep 30, 2025 | -3.39 Mn |
| Sep 30, 2025 | -3.39 Mn |
| Jun 30, 2025 | 1.67 Mn |
| Jun 30, 2025 | 1.67 Mn |
| Mar 31, 2025 | 2.21 Mn |
| Mar 31, 2025 | 2.21 Mn |
| Dec 31, 2024 | -744,000.00 |
| Dec 31, 2024 | -744,000.00 |
| Sep 30, 2024 | 738,000.00 |
| Sep 30, 2024 | 738,000.00 |
| Jun 30, 2024 | 272,000.00 |
| Jun 30, 2024 | 272,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Dec 31, 2023 | 32,000.00 |
| Jun 30, 2023 | 19,000.00 |
| Jun 30, 2023 | 19,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | 674,000.00 |
| Dec 31, 2021 | 674,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Sep 30, 2021 | 1,000.00 |
| Jun 30, 2021 | -447,000.00 |
| Jun 30, 2021 | -447,000.00 |
| Mar 31, 2021 | 450,000.00 |
| Mar 31, 2021 | 450,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Dec 31, 2020 | 1,000.00 |
| Sep 30, 2020 | 460,167.00 |
| Sep 30, 2020 | 460,167.00 |
| Jun 30, 2020 | 30,000.00 |
| Jun 30, 2020 | 30,000.00 |
| Dec 31, 2019 | -5.81 Mn |
| Dec 31, 2019 | -5.81 Mn |
| Mar 31, 2019 | 2,000.00 |
| Mar 31, 2019 | 2,000.00 |
| Dec 31, 2018 | 608,528.00 |
| Dec 31, 2018 | 608,528.00 |
| Dec 31, 2017 | 1.72 Mn |
| Dec 31, 2017 | 1.72 Mn |
| Dec 31, 2016 | 1.52 Mn |
| Dec 31, 2016 | 1.52 Mn |
| Dec 31, 2015 | -134,000.00 |
| Dec 31, 2015 | -134,000.00 |
| Sep 30, 2015 | -241,000.00 |
| Sep 30, 2015 | -241,000.00 |
| Jun 30, 2015 | 321,000.00 |
| Jun 30, 2015 | 321,000.00 |
| Mar 31, 2015 | -11,000.00 |
| Mar 31, 2015 | -11,000.00 |
| Dec 31, 2014 | 1.59 Mn |
| Dec 31, 2014 | 1.59 Mn |
| Sep 30, 2014 | 4,084.00 |
| Sep 30, 2014 | 4,084.00 |
| Jun 30, 2014 | 1,862.00 |
| Jun 30, 2014 | 1,862.00 |
| Mar 31, 2014 | 2.60 Mn |
| Mar 31, 2014 | 2.60 Mn |
| Dec 31, 2013 | 1.16 Mn |
| Dec 31, 2013 | 1.16 Mn |